{"id":"W4311483258","doi":"10.1016/j.jval.2022.09.269","title":"EE15 Cost-Consequence Analysis of Ofatumumab in Comparison With Other Disease-Modifying Therapies and Best Supportive Care for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"EVERSANA (Canada); Queen's University; Memorial University of Newfoundland; University of British Columbia; Novartis (Canada); Innovative Medicines Canada","funders":"","keywords":"Relapsing remitting; Ofatumumab; Medicine; Multiple sclerosis; Natalizumab; Physical therapy; Internal medicine; Psychiatry; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003552389,0.0008001446,0.001988518,0.001728704,0.0008080239,0.002122948,0.001972465,0.0008381735,0.003063242],"category_scores_gemma":[0.0132256,0.0005080645,0.004302122,0.003595298,0.0005796968,0.0005789252,0.0009579066,0.001760291,0.000125764],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.04778408,"about_ca_system_score_gemma":0.05104261,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9802098,"about_ca_topic_score_gemma":0.9785727,"domain_scores_codex":[0.9967965,0.001120655,0.0002441633,0.0002458679,0.0008183569,0.0007744029],"domain_scores_gemma":[0.9937282,0.002169725,0.0006186259,0.0001956286,0.002522601,0.000765192],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08338492,0.002173338,0.4874163,0.004583581,0.02724458,0.001309438,0.0004616624,0.2607185,0.001100544,0.01340484,0.04134317,0.07685912],"study_design_scores_gemma":[0.01394959,0.002941683,0.7683394,0.0009920502,0.01452627,0.000498631,0.001344459,0.1804661,0.0009913436,0.002488931,0.0131391,0.0003223917],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9380655,0.00984698,0.0009620797,0.002235837,0.0001790101,0.0005929536,0.04137623,0.00005279894,0.006688539],"genre_scores_gemma":[0.984782,0.001680961,0.000677756,0.0002747765,0.00003574339,0.00009240826,0.0100878,0.00001850841,0.002350033],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04778408,"threshold_uncertainty_score":0.3466994,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4139563000556837,"score_gpt":0.397819649341603,"score_spread":0.01613665071408071,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}